The CBR3-AS1/miR-25-3p/JNK1/MEK4 axis provides insight into breast cancer drug resistance mechanisms and theoretical support in the search for new breast cancer diagnostic markers and specific therapeutic targets. Here, CBR3 is linked to breast cancer.